EXAGEN INC. — Investor Relations & Filings
Filings indexed
397
across all filing types
Latest filing
2025-09-04
Director's Dealing
Country
US
United States of America
Listing
US
XGN
Exagen Inc. is a commercial-stage life sciences company focused on transforming the care continuum for patients with complex autoimmune diseases. Operating as a rheumatology specialty laboratory, the company develops and provides advanced testing solutions for the diagnosis, prognosis, and monitoring of these conditions. Its core offering is the AVISE® testing portfolio, which leverages proprietary biomarker technology to provide physicians with critical insights for timely and accurate differential diagnosis. These tools are designed to empower healthcare providers, particularly rheumatologists, in managing debilitating chronic diseases such as lupus and rheumatoid arthritis, ultimately aiming to improve patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 | 2025-09-04 | English | |
| Major Shareholding Notification 2025 | 2025-08-14 | English | |
| Major Shareholding Notification 2025 | 2025-08-14 | English | |
| 10-Q | 2025-07-29 | English | |
| 8-K | 2025-07-29 | English | |
| 8-K | 2025-07-17 | English |
Browse filings by year
22 years- 2026 12 filings
- 2025 42 filings
- 2024 44 filings
- 2023 54 filings
- 2022 48 filings
- 2021 57 filings
- 2020 54 filings
- 2019 47 filings
- 2017 4 filings
- 2016 7 filings
- 2015 7 filings
- 2014 5 filings
- 2013 1 filing
- 2012 2 filings
- 2011 5 filings
- 2010 1 filing
- 2009 1 filing
- 2008 2 filings
- 2007 1 filing
- 2006 1 filing
- 2005 1 filing
- 2003 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 11643229 | FORM 4 | 2025-09-04 | English | ||
| 11643231 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 11643232 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 11643230 | 10-Q | 2025-07-29 | English | ||
| 11643233 | 8-K | 2025-07-29 | English | ||
| 11643234 | 8-K | 2025-07-17 | English | ||
| 11643235 | Regulatory Filings 2025 | 2025-07-03 | English | ||
| 11643236 | Regulatory Filings 2025 | 2025-06-30 | English | ||
| 11643238 | Regulatory Filings 2025 | 2025-06-30 | English | ||
| 11643240 | S-3 | 2025-06-20 | English | ||
| 11643237 | FORM 4/A | 2025-06-12 | English | ||
| 11643239 | FORM 4 | 2025-06-12 | English | ||
| 11643241 | FORM 4 | 2025-06-12 | English | ||
| 11643242 | FORM 4 | 2025-06-12 | English | ||
| 11643243 | FORM 4 | 2025-06-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Other human health activities n.e.c
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
3billion Inc.
Uses an AI platform for rare disease diagnosis and continuo…
|
394800 | KR | Human health and social work ac… |
|
AdaptHealth Corp.
Provider of home medical equipment, supplies, and related h…
|
AHCO | US | Human health and social work ac… |
|
Addus HomeCare Corp
Provider of in-home personal care, home health, and hospice…
|
ADUS | US | Human health and social work ac… |
|
ADICON Holdings Limited
Provider of independent clinical laboratory services for ho…
|
9860 | KY | Human health and social work ac… |
|
ADVENTA BHD
Healthcare group manufacturing medical products, providing …
|
— | MY | Human health and social work ac… |
|
Aidigong Maternal & Child Health Limited
Provides comprehensive maternal and child healthcare, postp…
|
286 | HK | Human health and social work ac… |
|
Aimei Health Technology Co., Ltd.
A special purpose acquisition company (SPAC) focused on the…
|
AFJK | US | Human health and social work ac… |
|
Allcore
Holding company providing consulting services for small and…
|
CORE | IT | Human health and social work ac… |
|
ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A.
Provides diagnostic imaging, clinical analysis, and digital…
|
— | BR | Human health and social work ac… |
|
ALLURION TECHNOLOGIES, INC.
Offers a weight-loss platform featuring a procedure-less, s…
|
ALUR | US | Human health and social work ac… |
EXAGEN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33644/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33644 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33644 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33644 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33644}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for EXAGEN INC. (id: 33644)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.